From September 13 to 17, the Swiss Group for Clinical Cancer Research (SAKK) will have a significant presence at ESMO 2024. Prof. Dr. med. Ulrich Güller will have a proffered paper presentation about the SAKK 41/13 trial and Prof. Dr. Silke Gillessen will present STAMPEDE in a mini-oral presentation. Additionally, three SAKK trials will be showcased through poster presentations:

• SAKK 15/19 by Prof. Dr. med. Alfredo Addeo
• SAKK 16/96, 16/00, 16/01, 16/08, and 16/14 by Dr. med. Lorenz Frehner
• SAKK 21/18 (meta-analysis) by Dr. med. Louis Boismoreau

Don’t miss this opportunity to engage with cutting-edge oncology research. Attend these sessions to see the results and engage in discussions.